Pavion Blue Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.81M Sell
27,874
-334
-1% -$77.8K 2.96% 8
2025
Q4
$5.84M Sell
28,208
-28
-0.1% -$5.54K 2.42% 14
2025
Q3
$5.24M Buy
28,236
+1
+0% +$171 2.23% 16
2025
Q2
$4.31M Sell
28,235
-3,943
-12% -$606K 1.92% 17
2025
Q1
$5.34M Sell
32,178
-197
-0.6% -$30.8K 2.54% 15
2024
Q4
$4.68M Sell
32,375
-126
-0.4% -$19.5K 2.2% 16
2024
Q3
$5.27M Buy
32,501
+1
+0% +$159 2.45% 13
2024
Q2
$4.75M Sell
32,500
-105
-0.3% -$15.6K 2.34% 15
2024
Q1
$5.16M Sell
32,605
-85
-0.3% -$13.5K 2.55% 14
2023
Q4
$5.12M Sell
32,690
-124
-0.4% -$19K 2.83% 10
2023
Q3
$5.11M Buy
32,814
+176
+0.5% +$29K 3.11% 8
2023
Q2
$5.4M Buy
32,638
+298
+0.9% +$48.1K 3.15% 9
2023
Q1
$5.01M Sell
32,340
-35
-0.1% -$5.65K 3.09% 9
2022
Q4
$5.72M Sell
32,375
-305
-0.9% -$52.7K 3.65% 5
2022
Q3
$5.34M Sell
32,680
-9
-0% -$1.52K 3.83% 4
2022
Q2
$5.8M Buy
32,689
+18
+0.1% +$3.21K 3.92% 4
2022
Q1
$5.79M Buy
32,671
+1,247
+4% +$212K 3.39% 7
2021
Q4
$5.38M Sell
31,424
-205
-0.6% -$33.6K 3.12% 10
2021
Q3
$5.11M Sell
31,629
-115
-0.4% -$19.6K 3.17% 7
2021
Q2
$5.23M Sell
31,744
-293
-0.9% -$48.5K 3.14% 8
2021
Q1
$5.26M Sell
32,037
-502
-2% -$81.2K 3.47% 4
2020
Q4
$5.12M Sell
32,539
-236
-0.7% -$34.8K 3.51% 7
2020
Q3
$4.88M Buy
32,775
+500
+2% +$74K 3.75% 5
2020
Q2
$4.54M Buy
32,275
+1,274
+4% +$186K 3.96% 4
2020
Q1
$4.07M Buy
31,001
+3,617
+13% +$513K 4.22% 4
2019
Q4
$4M Buy
+27,384
New +$3.71M 3.96% 7

Other funds holding JNJ

Pavion Blue Capital's JNJ Position: Q1 2026 in Review

Pavion Blue Capital reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q1 2026, selling an estimated $77.8K and leaving 27,874 shares worth $6.81M. The position accounts for 2.96% of the portfolio, ranked #8.

Pavion Blue Capital first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Pavion Blue Capital held 27,874 shares of Johnson & Johnson worth $6.81M as of Q1 2026.
  • Pavion Blue Capital sold 334 Johnson & Johnson shares in Q1 2026, an estimated $77.8K.
  • Johnson & Johnson made up 2.96% of Pavion Blue Capital's portfolio in Q1 2026, its #8 holding.
  • Pavion Blue Capital first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.